Erosive osteoarthritis: a current review of a clinical challenge Sharon E. Banks Review Article 28 January 2010 Pages: 697 - 706
Off-label use of rituximab in systemic lupus erythematosus: a systematic review Eleanor MurrayMartin Perry Review Article 13 February 2010 Pages: 707 - 716
Expressions of IL-18 and its binding protein in peripheral blood leukocytes and kidney tissues of lupus nephritis patients Dawei HuXiaoqian LiuChunde Bao Original Article 08 February 2010 Pages: 717 - 721
Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab Herwig PieringerUlrike StubyGeorg Biesenbach Original Article 17 February 2010 Pages: 723 - 727
Renal disease in systemic sclerosis with normal serum creatinine Reem H. A. MohamedHania S. ZayedAmr Amin Original Article 23 February 2010 Pages: 729 - 737
Osteoarthritis of the hip or knee: which coexisting disorders are disabling? Kerstin G. ReeuwijkMariëtte de RooijJoost Dekker Original Article Open access 23 February 2010 Pages: 739 - 747
Validity, reliability, and comparison of the WOMAC osteoarthritis index and Lequesne algofunctional index in Turkish patients with hip or knee osteoarthritis Sibel BasaranRengin GuzelFusun Guler-Uysal Original Article 19 February 2010 Pages: 749 - 756
Juvenile idiopathic arthritis among Nigerians: a case study Olufemi O. AdelowoA. Umar Original Article 01 March 2010 Pages: 757 - 761
Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-α blockade Ashit SyngleKanchan VohraL. Kaur Original Article 05 March 2010 Pages: 763 - 770
The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus Meng-Yu WengChia-Tse WengMing-Fei Liu Original Article 02 March 2010 Pages: 771 - 775
Reinforcing a medical hypothesis with a new question: is there a subgroup of shrinking lungs syndrome that is induced by pleurisy in systemic lupus erythematosus and is this subgroup marked by anti-Ro/SSA? Fabricio Souza NevesThais Helena Otto da SilvaIvânio Alves Pereira Brief Report 20 March 2010 Pages: 777 - 779
Psychometric evaluation of the Moroccan version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in patients with ankylosing spondylitis Samira RostomKarima BenbouaazaNajia Hajjaj-Hassouni Brief Report 10 April 2010 Pages: 781 - 788
Primary Sjogren’s syndrome with anticentromere antibodies—a clinically distinct subset Dhiraj GulatiIrving KushnerMarina Magrey Case Report 19 January 2010 Pages: 789 - 791
The synergistic efficacy of adalimumab and pamidronate in a patient with ankylosing spondylitis Gleb SlobodinItzhak RosnerMajed Odeh Case Report 29 January 2010 Pages: 793 - 794
Adult presentation of Stickler syndrome type III Kayi LiCarter Thorne Case Report 30 January 2010 Pages: 795 - 797
Diffuse systemic sclerosis and autoimmune hepatitis: a unique association Carlos Ewerton Maia RodriguesCláudia Lobato BorgesJozélio Freire de Carvalho Case Report 07 February 2010 Pages: 799 - 801
Exertional paraspinal muscle rhabdomyolysis and compartment syndrome: a cause of back pain not to be missed Lori WikJeffrey M. PattersonAnna E. Oswald Case Report 11 February 2010 Pages: 803 - 805
A case of Hughes–Stovin syndrome associated with hyperhomocysteinemia Hyun-Ok KimHo Cheol KimSang-Il Lee Case Report 08 February 2010 Pages: 807 - 809
An unusual association: anti-Jo1 and anti-SRP antibodies in the serum of a patient with polymyositis Melinda VinczePeter A. MolnárKatalin Dankó Case Report 12 March 2010 Pages: 811 - 814
Renal cortical necrosis at presentation in a patient with systemic lupus erythematosus: an autopsy case report Megha S. UppinLiza RajasekharAruna K. Prayaga Case Report 19 February 2010 Pages: 815 - 818
Is polymyositis or dermatomyositis in patients with rheumatoid arthritis induced or unveiled by anti-tumor necrosis factor treatment? Takao NagashimaSeiji Minota Letter to Editor 20 April 2010 Pages: 819 - 820
Erratum to: Efficacy and safety of piascledine 300 versus chondroitin sulfate in a 6 months treatment plus 2 months observation in patients with osteoarthritis of the knee Karel PavelkaPhilippe CosteGerhard Krejci Erratum 30 April 2010 Pages: 821 - 821